These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 15302196)

  • 1. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient.
    Peden AH; Head MW; Ritchie DL; Bell JE; Ironside JW
    Lancet; 2004 Aug 7-13; 364(9433):527-9. PubMed ID: 15302196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay.
    Wadsworth JD; Joiner S; Hill AF; Campbell TA; Desbruslais M; Luthert PJ; Collinge J
    Lancet; 2001 Jul; 358(9277):171-80. PubMed ID: 11476832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.
    Takeuchi A; Kobayashi A; Ironside JW; Mohri S; Kitamoto T
    J Biol Chem; 2013 Jul; 288(30):21659-66. PubMed ID: 23792955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant CJD. 18 years of research and surveillance.
    Diack AB; Head MW; McCutcheon S; Boyle A; Knight R; Ironside JW; Manson JC; Will RG
    Prion; 2014; 8(4):286-95. PubMed ID: 25495404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia.
    Peden A; McCardle L; Head MW; Love S; Ward HJ; Cousens SN; Keeling DM; Millar CM; Hill FG; Ironside JW
    Haemophilia; 2010 Mar; 16(2):296-304. PubMed ID: 20070383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease.
    Bishop MT; Diack AB; Ritchie DL; Ironside JW; Will RG; Manson JC
    Brain; 2013 Apr; 136(Pt 4):1139-45. PubMed ID: 23449776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc.
    Jones M; Peden AH; Prowse CV; Gröner A; Manson JC; Turner ML; Ironside JW; MacGregor IR; Head MW
    J Pathol; 2007 Sep; 213(1):21-6. PubMed ID: 17614097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dealing with the uncertain risk of variant Creutzfeldt-Jakob disease transmission by coagulation replacement products.
    Millar CM; Makris M
    Br J Haematol; 2012 Aug; 158(4):442-52. PubMed ID: 22775486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Red-backed vole brain promotes highly efficient in vitro amplification of abnormal prion protein from macaque and human brains infected with variant Creutzfeldt-Jakob disease agent.
    Nemecek J; Nag N; Carlson CM; Schneider JR; Heisey DM; Johnson CJ; Asher DM; Gregori L
    PLoS One; 2013; 8(10):e78710. PubMed ID: 24205298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid amplification of prions from variant Creutzfeldt-Jakob disease cerebrospinal fluid.
    Barria MA; Lee A; Green AJ; Knight R; Head MW
    J Pathol Clin Res; 2018 Apr; 4(2):86-92. PubMed ID: 29665324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracerebral distribution of the abnormal isoform of the prion protein in sporadic Creutzfeldt-Jakob disease and fatal insomnia.
    Parchi P; Capellari S; Gambetti P
    Microsc Res Tech; 2000 Jul; 50(1):16-25. PubMed ID: 10871544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variant Creutzfeldt-Jakob disease in a transfusion recipient: coincidence or cause?
    Chohan G; Llewelyn C; Mackenzie J; Cousens S; Kennedy A; Will R; Hewitt P
    Transfusion; 2010 May; 50(5):1003-6. PubMed ID: 20230536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion infectivity in variant Creutzfeldt-Jakob disease rectum.
    Wadsworth JD; Joiner S; Fox K; Linehan JM; Desbruslais M; Brandner S; Asante EA; Collinge J
    Gut; 2007 Jan; 56(1):90-4. PubMed ID: 16763054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelets as a substrate source for the in vitro amplification of the abnormal prion protein (PrP) associated with variant Creutzfeldt-Jakob disease.
    Jones M; Peden AH; Yull H; Wight D; Bishop MT; Prowse CV; Turner ML; Ironside JW; MacGregor IR; Head MW
    Transfusion; 2009 Feb; 49(2):376-84. PubMed ID: 18980616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease.
    Schulz-Schaeffer WJ; Giese A; Windl O; Kretzschmar HA
    Clin Neuropathol; 1996; 15(6):353-7. PubMed ID: 8937783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review: pathology of variant Creutzfeldt-Jakob disease.
    Peden AH; Ironside JW
    Folia Neuropathol; 2004; 42 Suppl A():85-91. PubMed ID: 15449463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological diagnosis of variant Creutzfeldt-Jakob disease.
    Ironside JW; McCardle L; Horsburgh A; Lim Z; Head MW
    APMIS; 2002 Jan; 110(1):79-87. PubMed ID: 12064259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian sporadic CJD analysis supports endogenous determinants of molecular-clinical profiles.
    Lewis V; Hill AF; Klug GM; Boyd A; Masters CL; Collins SJ
    Neurology; 2005 Jul; 65(1):113-8. PubMed ID: 16009895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant Creutzfeldt-Jakob disease strain is identical in individuals of two PRNP codon 129 genotypes.
    Diack AB; Boyle A; Plinston C; Hunt E; Bishop MT; Will RG; Manson JC
    Brain; 2019 May; 142(5):1416-1428. PubMed ID: 30938429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.